With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development.
Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
Xiaosong Li,Min Min,N. Du,Ying Gu,T. Hode,M. Naylor,Dianjun Chen,R. Nordquist,Wei R. Chen
Published 2013 in Clinical and Developmental Immunology
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Clinical and Developmental Immunology
- Publication date
2013-03-04
- Fields of study
Biology, Medicine, Materials Science, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.